Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of the Response to Anti-TNFs DMARDs Based on the RheumaKit ® Platform (RK-Tx-01)

NCT02928276 is registered in ClinicalTrials.gov with DNAlytics as lead sponsor.

NCT NCT02928276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02928276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of the Response to Anti-TNFs DMARDs Based on the RheumaKit ® Platform (RK-Tx-01)
Lead sponsor
DNAlytics
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2016
Completion date
April 30, 2020
Enrollment
110 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis